Dynavax (DVAX) Misses Q1 EPS by 14c

Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.63), $0.14 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $165 million versus the consensus estimate of $148 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
• Jabil (JBL) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY Guidance